• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Medicare Part D

Prescription medicine pill expense
Favicon Fierce Healthcare

HRSA taps Pfizer, AbbVie, others for revised 340B rebate pilot

The list of approved participants and drugs is larger than the controversial pilot's first attempted launch.
Dave Muoio Oct 2, 2026 1:00pm
Pills medicine in Dollar sign shape on blue background

Brand-name drug prices climb with age in US, fall abroad: report

May 29, 2026 8:10am
Two dosing pens of semaglutide
Favicon Fierce Healthcare

CMS delays Part D GLP-1 model amid skepticism from insurers

Apr 22, 2026 12:00pm
Cost of drugs
Favicon Fierce Healthcare

CMMI proposes new models to lower drug prices in Parts B, D

Dec 22, 2025 12:00pm
Richard Francis Teva CEO Teva CEO

Teva's subdued outlook puts damper on strong 2024 results

Jan 29, 2025 1:13pm
cash  money

Congress has 'time-limited' chance to fix high drug costs

Jul 14, 2021 10:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings